Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, D Miller C, Lim LL, Suhler EB, Al-Dhibi HA et al..  2025.  Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease.. Ocul Immunol Inflamm. 33(2):263-270.

Yan D, N Prajna V, Lalitha P, Sansanayudh W, Satitpitakul V, Laovirojjanakul W, Chaudhary M, Bountogo M, Sie A, Coulibaly B et al..  2024.  Association of weather variables with pathogens contributing to conjunctivitis worldwide.. Clin Infect Dis. 

O'Brien KS, Arzika AM, Amza A, Maliki R, Aichatou B, Bello IMamane, Beidi D, Galo N, Harouna N, Karamba AM et al..  2024.  Azithromycin to Reduce Mortality - An Adaptive Cluster-Randomized Trial.. N Engl J Med. 391(8):699-709.

Seitzman GD, Prajna L, N Prajna V, Sansanayudh W, Satitpitakul V, Laovirojjanakul W, Chen C, Zhong L, Ouimette K, Redd T et al..  2024.  Biomarker Detection and Validation for Corneal Involvement in Patients With Acute Infectious Conjunctivitis.. JAMA Ophthalmol. 

Tran H, H? T, Hoang L, Tran Y, Ruder K, Zhong L, Chen C, Liu YH, Yu D, Abraham T et al..  2024.  Coxsackievirus A24 Causing Acute Conjunctivitis in a 2023 outbreak in Vietnam.. Int J Infect Dis. :107133.

Oldenburg CE, Ouattara M, Bountogo M, Boudo V, Ouedraogo T, Compaoré G, Dah C, Zakane A, Coulibaly B, Bagagnan C et al..  2024.  Mass Azithromycin Distribution to Prevent Child Mortality in Burkina Faso: The CHAT Randomized Clinical Trial.. JAMA. 331(6):482-490.

Acharya NR, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Gonzales JA, Lim LL, Suhler EB, Al-Dhibi HA et al..  2024.  Outcomes in Patients with Vogt-Koyanagi-Harada Disease from the First-line Antimetabolites for Steroid-sparing Treatment Uveitis Trial.. Am J Ophthalmol. 

Arzika AM, Abdou A, Maliki R, Beido N, Kadri B, Harouna AN, Galo AN, Alio MK, Lebas E, Oldenburg CE et al..  2024.  Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).. PLoS Med. 21(5):e1004386.

Deiner MS, Deiner NA, Hristidis V, McLeod SD, Doan T, Lietman TM, Porco TC.  2024.  Use of Large Language Models to Assess the Likelihood of Epidemics From the Content of Tweets: Infodemiology Study.. J Med Internet Res. 26:e49139.

Chattopadhyay A, Rathinam SR, Gonzales JA, Kelly NK, Thundikandy R, Kanakath A, S Murugan B, Vedhanayaki R, Lim LL, Suhler EB et al..  2023.  Association between Quality of Life and Visual Acuity in a Randomized Clinical Trial of Patients with Uveitis Taking Antimetabolites.. Ocul Immunol Inflamm. :1-9.

Tsui E, Sella R, Tham V, Kong AW, McClean E, Goren L, Bahar I, Cherian N, Ramirez J, Hughes RE et al..  2023.  Pathogen Surveillance for Acute Infectious Conjunctivitis.. JAMA Ophthalmol. 

Hazel A, Arzika AM, Abdou A, Lebas E, Porco TC, Maliki R, Doan T, Lietman TM, Keenan JD, Blumberg S.  2023.  Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger.. Am J Trop Med Hyg. 

Arzika AM, Maliki R, E Goodhew B, Rogier E, Priest JW, Lebas E, O'Brien KS, Le V, Oldenburg CE, Doan T et al..  2022.  Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.. Nat Commun. 13(1):976.

Coulibaly B, Kiemde D, Zonou G, Sie A, Dah C, Bountogo M, Brogdon J, Hu H, Lebas E, Porco TC et al..  2022.  Effect of Single-dose Azithromycin on Pneumococcal Carriage and Resistance: A Randomized Controlled Trial.. Pediatr Infect Dis J. 41(9):728-730.

Oldenburg CE, Sie A, Bountogo M, Zakane A, Compaoré G, Ouedraogo T, Koueta F, Lebas E, Brogdon J, Nyatigo F et al..  2022.  Neonatal azithromycin administration for prevention of infant mortality.. NEJM Evid. 1(4):EVIDoa2100054.

Tsui E, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA et al..  2022.  Outcomes of uveitic macular edema in the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.. Ophthalmology. 

O'Brien KS, Arzika AM, Amza A, Maliki R, Ousmane S, Kadri B, Nassirou B, Mankara AKaramba, Harouna ANaser, Colby E et al..  2021.  Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).. BMC Public Health. 21(1):822.

Coulibaly B, Sie A, Dah C, Bountogo M, Ouattara M, Compaoré A, Nikiema M, Tiansi JNankoné, Sibiri NDembélé, Brogdon JM et al..  2021.  Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial.. Malar J. 20(1):360.

Doan T, Gebre T, Ayele B, Zerihun M, Hinterwirth A, Zhong L, Chen C, Ruder K, Zhou Z, Emerson PM et al..  2021.  Effect of Azithromycin on the Ocular Surface Microbiome of Children in a High Prevalence Trachoma Area.. Cornea. 

Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L, Nyatigo F, Cook CA, Hinterwirth A, Lebas E et al..  2021.  Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.. JAMA. 

Kaur G, Seitzman GD, Lietman TM, McLeod SD, Porco TC, Doan T, Deiner MS.  2021.  Keeping an eye on pink eye: a global conjunctivitis outbreak expert survey.. Int Health. 

Sie A, Coulibaly B, Dah C, Bountogo M, Ouattara M, Compaoré G, Brogdon JM, Godwin WW, Lebas E, Doan T et al..  2021.  Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial.. BMC Pediatr. 21(1):130.

Sie A, Dah C, Bountogo M, Ouattara M, Nebie E, Coulibaly B, Brogdon JM, Godwin WW, Lebas E, Doan T et al..  2020.  Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial.. Am J Trop Med Hyg. 

Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E et al..  2020.  Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.. N Engl J Med. 383(20):1941-1950.

Doan T, Hinterwirth A, Worden L, Arzika AM, Maliki R, Chen C, Zhong L, Zhou Z, Acharya NR, Porco TC et al..  2020.  Post-antibiotic Ocular Surface Microbiome in Children: A Cluster-Randomized Trial.. Ophthalmology. 127(8):1127-1130.

Takhar JS, Joye AS, Somkijrungroj T, Laovirojjanakul W, Lin C-P, Lietman TM, Porco TC, Keenan JD, Gebreegziabher EA, Seitzman GD et al..  2019.  A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol.. BMJ Open. 9(12):e033175.

Sie A, Ouattara M, Bountogo M, Bagagnan C, Coulibaly B, Boudo V, Lebas E, Brogdon JM, Lin Y, Bärnighausen T et al..  2019.  A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol.. Trials. 20(1):675.

Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, S Murugan B, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T et al..  2019.  Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.. JAMA. 322(10):936-945.

Ray KJ, Cotter SY, Arzika AM, Kim J, Boubacar N, Zhou Z, Zhong L, Porco TC, Keenan JD, Lietman TM et al..  2019.  High-throughput sequencing of pooled samples to determine community-level microbiome diversity.. Ann Epidemiol. 39:63-68.

Keenan JD, Arzika AM, Maliki R, Boubacar N, Adamou SElh, Ali MMoussa, Cook C, Lebas E, Lin Y, Ray KJ et al..  2019.  Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.. N Engl J Med. 380(23):2207-2214.

Doan T, Arzika AM, Hinterwirth A, Maliki R, Zhong L, Cummings S, Sarkar S, Chen C, Porco TC, Keenan JD et al..  2019.  Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger.. N Engl J Med. 380(23):2271-2273.

Keenan JD, Bailey RL, West SK, Arzika AM, Hart J, Weaver J, Kalua K, Mrango Z, Ray KJ, Cook C et al..  2018.  Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.. N Engl J Med. 378(17):1583-1592.

Doan T, Hinterwirth A, Arzika AM, Cotter SY, Ray KJ, O'Brien KS, Zhong L, Chow ED, Zhou Z, Cummings SL et al..  2018.  Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial.. Open Forum Infect Dis. 5(8):ofy182.

Doan T, Arzika AM, Ray KJ, Cotter SY, Kim J, Maliki R, Zhong L, Zhou Z, Porco TC, Vanderschelden B et al..  2017.  Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.. Clin Infect Dis. 64(9):1147-1153.